Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery.

Healthpeak Properties

Analysts have been eager to weigh in on the Technology sector with new ratings on DigitalOcean Holdings (DOCN) and Shift4 Payments (FOUR). DigitalO...

Analysts’ Opinions Are Mixed on These Technology Stocks: DigitalOcean Holdings (DOCN) and Shift4 Payments (FOUR)

In a report released on July 26, Rishi Jaluria from RBC Capital maintained a Hold rating on DocuSign, with a price target of $55.00. Jaluria covers...

DocuSign (DOCU) Gets a Hold from RBC Capital

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Spectral AI (MDAI) and Doximity (DOCS). Spectral A...

Analysts Conflicted on These Healthcare Names: Spectral AI (MDAI) and Doximity (DOCS)

Analysts are intrested in these 5 stocks: ( ($CRWV) ), ( ($NBIS) ), ( ($DOCN) ), ( ($AFRM) ) and ( ($CRSR) ). Here is a breakdown of their recent


CoreWeave, Nebius, DigitalOcean, Affirm, Corsair Trending Strong

DigitalOcean Holdings ( ($DOCN) ) has provided an announcement. On July 23, 2026, DigitalOcean Holdings, Inc. completed the repurchase of approxima...

DigitalOcean restructures capital via major debt repurchase

The latest announcement is out from DigitalOcean Holdings ( ($DOCN) ). DigitalOcean Holdings, Inc. disclosed that Freshfields US LLP has issued a l...

DigitalOcean advances legal approval for new stock offering

Adocia SA ( ($FR:ADOC) ) has shared an update. Adocia reported a cash position of €9.7 million at June 30, 2026, down from €17.2 million at year-en...

Adocia Extends Cash Runway as BioChaperone and AdoXLong Platforms Advance in Diabetes and Obesity

In a report released yesterday, Guillaume Galland from Barclays maintained a Hold rating on DocMorris. The company’s shares closed yesterday at CHF...

Barclays Reaffirms Their Hold Rating on DocMorris (DOCM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tempus AI, Inc. Class A (TEM), Doximity (DOCS) and...

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Doximity (DOCS) and PTC Therapeutics (PTCT)

Barclays analyst Raimo Lenschow maintained a Buy rating on DigitalOcean Holdings today and set a price target of $160.00. According to TipRanks, Le...

DigitalOcean Holdings (DOCN) Gets a Buy from Barclays

Stocks ended the week lower as weakness in technology shares and disappointing corporate outlooks weighed on the major U.S. indexes. The Dow Jones ...

The Week That Was, The Week Ahead: Macro and Markets, July 19

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Sprout Social (SPT) and DigitalOcean Holdings (DOC...

Analysts Have Conflicting Sentiments on These Technology Companies: Sprout Social (SPT) and DigitalOcean Holdings (DOCN)

Dr. Martens Plc ( ($GB:DOCS) ) has provided an announcement. Dr. Martens plc reported that all resolutions at its 15 July Annual General Meeting we...

Dr. Martens Wins Strong Shareholder Backing at Annual General Meeting

The latest announcement is out from DocMorris ( ($CH:DOCM) ). DocMorris reported a sharp acceleration in growth in the second quarter of 2026, with...

DocMorris accelerates Rx and digital growth, tracks toward 2026 EBITDA breakeven

RBC Capital analyst Ryan Halsted maintained a Buy rating on Doximity yesterday and set a price target of $28.00. Halsted covers the Healthcare sect...

RBC Capital Sticks to Their Buy Rating for Doximity (DOCS)

UBS analyst Michael Goldsmith maintained a Hold rating on Healthpeak Properties today and set a price target of $21.50. According to TipRanks, Gold...

UBS Sticks to Its Hold Rating for Healthpeak Properties (DOC)

DigitalOcean stock took off on Tuesday alongside a positive update for the company’s upcoming earnings report.


DigitalOcean (DOCN) Stock Soars on a Strong Q2 Earnings Update

In a report released today, Martin Comtesse from Jefferies maintained a Buy rating on DocMorris, with a price target of CHF9.50. According to TipRa...

Jefferies Keeps Their Buy Rating on DocMorris (DOCM)

Analysts are intrested in these 5 stocks: ( ($CYTK) ), ( ($PRME) ), ( ($DOCS) ), ( ($WBD) ) and ( ($LQDA) ). Here is a breakdown of their recent


CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts

Retail giant Walmart ($WMT) is slashing prices of Wellness products and increasing access to weight-loss drugs as it looks to beef up demand from h...

Walmart Sizes Up Wellness Gains With Price Cuts and GLP-1 Drug Moves

An announcement from Dr. Martens Plc ( ($GB:DOCS) ) is now available. Dr. Martens plc has increased its ordinary share capital through the admissio...

Dr. Martens Adds New Shares to LSE Under Employee Schemes

The latest announcement is out from Dr. Martens Plc ( ($GB:DOCS) ). Dr. Martens plc has confirmed that its issued ordinary share capital currently ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DOC	$22.82	+1.33%	7.36M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DOC	$22.82	+1.3%	7.36M
3
4
5
6

DOC

DOC

Get Healthpeak Properties Data in Excel

Get Healthpeak Properties Data in Excel